Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor Models
检查点激酶 1 抑制剂 Prexasertib 作为单一药物或化学增强剂对一系列临床前儿科肿瘤模型的广谱活性
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-18-2728
Caitlin D Lowery, Michele Dowless, Matthew Renschler, Wayne Blosser, Alle B VanWye, Jennifer R Stephens, Philip W Iversen, Aimee Bence Lin, Richard P Beckmann, Kateryna Krytska, Kristina A Cole, John M Maris, Douglas S Hawkins, Brian P Rubin, Raushan T Kurmasheva, Peter J Houghton, Richard Gorlick,